产品名称 Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) 产品规格 50µg 200µg 1mg 5mg 有效成分含量 99% 是否进口 是 用途范围 Positive Control; Immunogen; SDS-PAGE; WB. 如果需要有生物活性的蛋白,请参见活性蛋白。 包装规格 0.5kg 来源 原核表达 片段与标签 Lys2308~His2537 ...
Clinical and Pathological Characteristics of BRCA2 Positive Breast Cancer in Egyptian Female PatientsClinical and Pathological Characteristics of BRCA2 Positive Breast Cancer in Egyptian Female PatientsMutations in the BRCA1 and BRCA2 genes confer greater risk of developing breast cancer. Early age at ons...
Jacopo WabersichLucia BorgatoMario Bari乳腺癌(英文)Artioli G, Azzarello G, Meggiolaro F, Wabersich J, Borgato L, et al. (2013) Case Report: Complete Clinical Response of a Young Patient with a BRCA 2 Positive Metastatic Breast Cancer. Advances in Breast Cancer Research 2: 56-59....
7.Byrski T, Huzarski T, Dent R, et al: Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Can- cer Res Treat 147:401-405, 2014 8.Byrski T, Gronwald J, Huzarski...
中文名称:乳腺癌易感蛋白2(BRCA2)重组蛋白英文名称:Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) 保存条件:避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月纯度规格:> 95% 产品类别:重组蛋白 货号::BES20998RP 乳腺癌易感蛋白2(BRCA2)重组蛋白 ...
1.Byrski T, Huzarski T, Dent R, et al:Pathologic complete response to neoadjuvant cisplatin inBRCA1 positive breast cancer patients. Breast Cancer Res Treat 147:401-5, 2014 2.KaufmanB,ShapiraFrommer R, Schmutzler RK, et al: Olaparib m...
应用Positive Control; Immunogen; SDS-PAGE; WB. 如果需要有生物活性的蛋白,请参见活性蛋白 序列 用法 Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex. 储存 避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
'The Office' Star Jenna Fischer Has Breast Cancer Ex-MTV VJ Ananda Lewis Has Stage IV Breast Cancer Dr. Thaïs Aliabadi’s Breast Cancer Risk Assessment How Dense Breasts Affect Your Breast Cancer Risk Danielle Fishel Reveals Breast Cancer Diagnosis ...
Generally ER and PR positive ▸ Negative for HER2/neu overexpression/gene amplification Differential Diagnosis ▸ NA View chapter Chapter Familial Breast Cancer Breast Pathology (Second Edition) Book2011, Breast Pathology (Second Edition) Anita Bane, ... Frances P O’Malley Explore book Introduction...
Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history context and objective: brca1 and brca2 are the two principal hereditary breast cancer susceptibility genes, and the prevalence of their mutations among bra... RM Dufloth,S Carvalho,JK Heinrich,...